I am not concerned about whether or not they break even Q3. I want to see PODRAS trail start this year like they said in the earnings report. IPCI value will appreciate greatly when PODRAS concept is proven to some degree in testing. That's where the speculative money is at when the word is out. That's what's going to turn your 20k shares into a million dollar. Otherwise, this is just a traders heaven.
Although, the Opioid market is still substantial, but we're seeing a trend where people and doctors are moving away from using Opioid. Thanks to the media, this is sort of a wake up call. However, that's not going to be an immediate change I don't think, but it feels like the direction of the wind might be changing years down the road. Rexista value can potentially degrade as time go by. In the near term, big pharma will likely still want to profit off of Rexista partnership. Hope we get a swift resolution to to law suit in July.
That's why PODRAS is it, or other drugs that has a large market but can also use the abuse resistant technology. This is what I am hoping to see some development in the second half of this year. It's a major factor for me to determine whether to hold or continue to trade.
News 
Market Data 
Discover 
